These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8858665)

  • 1. The future of polio immunization in the United States: are we ready for change?
    Paradiso PR
    Pediatr Infect Dis J; 1996 Aug; 15(8):645-9. PubMed ID: 8858665
    [No Abstract]   [Full Text] [Related]  

  • 2. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
    Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW
    JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO policy statement on polio vaccines.
    Wkly Epidemiol Rec; 1995 Dec; 70(49):346-7. PubMed ID: 8652353
    [No Abstract]   [Full Text] [Related]  

  • 5. Poliomyelitis in the United States: the final chapter?
    Modlin JF
    JAMA; 2004 Oct; 292(14):1749-51. PubMed ID: 15479943
    [No Abstract]   [Full Text] [Related]  

  • 6. Change from oral poliovirus vaccine to inactivated poliovirus vaccine.
    Mele A; Jefferson T; Franco E; Salmaso S
    Lancet; 2002 Oct; 360(9340):1178. PubMed ID: 12387987
    [No Abstract]   [Full Text] [Related]  

  • 7. Polio vaccines: WHO position paper – March, 2016.
    Wkly Epidemiol Rec; 2016 Mar; 91(12):145-68. PubMed ID: 27039410
    [No Abstract]   [Full Text] [Related]  

  • 8. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Prevots DR; Burr RK; Sutter RW; Murphy TV;
    MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated polio vaccine for the United States: a missed vaccination opportunity.
    Plotkin SA
    Pediatr Infect Dis J; 1995 Oct; 14(10):835-9. PubMed ID: 8584307
    [No Abstract]   [Full Text] [Related]  

  • 10. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral poliomyelitis vaccine: time to change?
    Swennen B; Levy J
    Vaccine; 2001 Mar; 19(17-19):2262-7. PubMed ID: 11257345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded programme on immunization. Statement on poliomyelitis eradication.
    Wkly Epidemiol Rec; 1995 Dec; 70(49):345-6. PubMed ID: 8652352
    [No Abstract]   [Full Text] [Related]  

  • 13. Indian experts favour IPV to eradicate polio.
    Sharma DC
    Lancet; 2003 Oct; 362(9392):1292. PubMed ID: 14577440
    [No Abstract]   [Full Text] [Related]  

  • 14. Polio endgame: the global introduction of inactivated polio vaccine.
    Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
    Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The logic of causation and the risk of paralytic poliomyelitis for an American child.
    Ridgway D
    Epidemiol Infect; 2000 Feb; 124(1):113-20. PubMed ID: 10722138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inactivated polio vaccine].
    Pachón del Amo I
    Aten Primaria; 2004 Nov; 34(8):392-4. PubMed ID: 15546532
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polio vaccines, eradication and posterradication].
    Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
    Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
    Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
    Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
    Khan MM; Sharma S; Tripathi B; Alvarez FP
    Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polio endgame. The exit strategy.
    Roberts L
    Science; 2004 Mar; 303(5666):1969-71. PubMed ID: 15044782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.